Sound Income Strategies »

Oncolytics Biotech shares owned by Sound Income Strategies

Quarter-by-quarter ownership of Oncolytics Biotech (ONCY) shares owned by Sound Income Strategies from 13F filings

Historical chart of Sound Income Strategies investment in Oncolytics Biotech

Tip: Access up to 7 years of quarterly data

All positions including Oncolytics Biotech held by Sound Income Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncolytics Biotech by Sound Income Strategies

Quarter filed Position value Share count Share price at filing
2025-09-30 $241 194 1.24
2025-06-30 $150 194 0.77
2025-03-31 $106 194 0.55

More positions owned by Sound Income Strategies

Sixth Street Specialty Lending Cef (TSLX)
Ares Capital Corp Cef (ARCC)
Hercules Capital Cef (HTGC)
Golub Cap Bdc Cef (GBDC)
Ishares 0-5 Year High Yield Corporate Bond Etf Etf (SHYG)
Blue Owl Capital Corporation Cef (OBDC)
Vaneck Emerging Markets High Yield Bond Etf Etf (HYEM)
Ishares J.p. Morgan Em High Yield Bond Etf Etf (EMHY)
Pennantpark Floating Rate Cap Cef (PFLT)
Blackstone Secd Lending Cef (BXSL)
Citigroup Stock (C)
Sound Enhanced Fixed Income Etf Etf (FXED)
Enbridge Stock (ENB)
Abbvie Stock (ABBV)
Cisco Sys Stock (CSCO)

View all positions for Sound Income Strategies

Top funds holding Oncolytics Biotech

Citadel Advisors
Marshall Wace
Seeds Investor
Goldman Sachs Group
International Assets Investment Management
Franklin Resources
Royal Bank of Canada
Geode Capital Management
CIBC World Markets
LPL Financial
Headinvest
Badgley Phelps Wealth Managers
Bank Of Montreal
Ball & Co Wealth Management
SeaCrest Wealth Management

View all funds holding Oncolytics Biotech